FDA authorizes Pfizer booster for kids 5-11 years old

WASHINGTON, D.C. (NBC) – The Food and Drug Administration authorized a booster dose of the Pfizer-BioNTech COVID-19 vaccine for children ages 5 to 11.

Children in the age group can get a booster shot at least five months after they’ve received the primary two-dose series, the FDA said in a statement Tuesday.

The booster shot is 10 micrograms, the same dosage as the primary series for the age group and a third of the dosage given to people ages 12 and up.

The FDA’s decision will now go to the Centers for Disease Control and Prevention, which will make a recommendation about how the boosters should be used for the age group.

The CDC’s independent group of advisers, known as the Advisory Committee on Immunization Practices, is expected to discuss the booster during a scheduled meeting Thursday.

CDC Director Dr. Rochelle Walensky is expected to issue a final recommendation following that meeting. Shots could begin as early as Friday.

Less than a third of the 28 million 5-to-11-year-old children in the United States have received two doses of a COVID vaccine, according to data from the CDC.

Leave a Comment:

Note: By commenting below you agree to abide by the KOBI5.com commenting guidelines. View the KOBI5.com Comment Board Guidelines »

Skip to content